BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31306400)

  • 1. Narcolepsy and Pandemic Influenza Vaccination: What We Need to Know to be Ready for the Next Pandemic.
    Edwards K; Lambert PH; Black S
    Pediatr Infect Dis J; 2019 Aug; 38(8):873-876. PubMed ID: 31306400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meeting report narcolepsy and pandemic influenza vaccination: What we know and what we need to know before the next pandemic? A report from the 2nd IABS meeting.
    Edwards K; Hanquet G; Black S; Mignot E; Jankosky C; Shimabukuro T; Miller E; Nohynek H; Neels P
    Biologicals; 2019 Jul; 60():1-7. PubMed ID: 31130313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: what is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants.
    Ahmed SS; Schur PH; MacDonald NE; Steinman L
    J Autoimmun; 2014 May; 50():1-11. PubMed ID: 24559657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Narcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines - Multi-country assessment.
    Weibel D; Sturkenboom M; Black S; de Ridder M; Dodd C; Bonhoeffer J; Vanrolleghem A; van der Maas N; Lammers GJ; Overeem S; Gentile A; Giglio N; Castellano V; Kwong JC; Murray BJ; Cauch-Dudek K; Juhasz D; Campitelli M; Datta AN; Kallweit U; Huang WT; Huang YS; Hsu CY; Chen HC; Giner-Soriano M; Morros R; Gaig C; Tió E; Perez-Vilar S; Diez-Domingo J; Puertas FJ; Svenson LW; Mahmud SM; Carleton B; Naus M; Arnheim-Dahlström L; Pedersen L; DeStefano F; Shimabukuro TT
    Vaccine; 2018 Oct; 36(41):6202-6211. PubMed ID: 30122647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change in risk for narcolepsy over time and impact of definition of onset date following vaccination with AS03 adjuvanted pandemic A/H1N1 influenza vaccine (Pandemrix) during the 2009 H1N1 influenza pandemic.
    Granath F; Gedeborg R; Smedje H; Feltelius N
    Pharmacoepidemiol Drug Saf; 2019 Aug; 28(8):1045-1053. PubMed ID: 31062443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Pandemrix and Arepanrix, two pH1N1 AS03-adjuvanted vaccines differentially associated with narcolepsy development.
    Jacob L; Leib R; Ollila HM; Bonvalet M; Adams CM; Mignot E
    Brain Behav Immun; 2015 Jul; 47():44-57. PubMed ID: 25452148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic differences between AS03 adjuvanted influenza A (H1N1) pandemic vaccines: implications for pandemrix-associated narcolepsy risk.
    Vaarala O; Vuorela A; Partinen M; Baumann M; Freitag TL; Meri S; Saavalainen P; Jauhiainen M; Soliymani R; Kirjavainen T; Olsen P; Saarenpää-Heikkilä O; Rouvinen J; Roivainen M; Nohynek H; Jokinen J; Julkunen I; Kilpi T
    PLoS One; 2014; 9(12):e114361. PubMed ID: 25501681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of Narcolepsy after AS03 Adjuvanted Pandemic A/H1N1 2009 Influenza Vaccine in Adults: A Case-Coverage Study in England.
    Stowe J; Andrews N; Kosky C; Dennis G; Eriksson S; Hall A; Leschziner G; Reading P; Shneerson JM; Donegan K; Miller E
    Sleep; 2016 May; 39(5):1051-7. PubMed ID: 26856903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France.
    Dauvilliers Y; Arnulf I; Lecendreux M; Monaca Charley C; Franco P; Drouot X; d'Ortho MP; Launois S; Lignot S; Bourgin P; Nogues B; Rey M; Bayard S; Scholz S; Lavault S; Tubert-Bitter P; Saussier C; Pariente A;
    Brain; 2013 Aug; 136(Pt 8):2486-96. PubMed ID: 23884811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Did narcolepsy occur following administration of AS03-adjuvanted A(H1N1) pandemic vaccine in Ontario, Canada? A review of post-marketing safety surveillance data.
    Harris T; Wong K; Stanford L; Fediurek J; Crowcroft N; Deeks S
    Euro Surveill; 2014 Sep; 19(36):. PubMed ID: 25232921
    [No Abstract]   [Full Text] [Related]  

  • 11. Incidence of narcolepsy before and after MF59-adjuvanted influenza A(H1N1)pdm09 vaccination in South Korean soldiers.
    Kim WJ; Lee SD; Lee E; Namkoong K; Choe KW; Song JY; Cheong HJ; Jeong HW; Heo JY
    Vaccine; 2015 Sep; 33(38):4868-72. PubMed ID: 26238720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reassessment of the risk of narcolepsy in children in England 8 years after receipt of the AS03-adjuvanted H1N1 pandemic vaccine: A case-coverage study.
    Stowe J; Andrews N; Gringras P; Quinnell T; Zaiwalla Z; Shneerson J; Miller E
    PLoS Med; 2020 Sep; 17(9):e1003225. PubMed ID: 32926731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Explorations of clinical trials and pharmacovigilance databases of MF59®-adjuvanted influenza vaccines for associated cases of narcolepsy.
    Tsai TF; Crucitti A; Nacci P; Nicolay U; Della Cioppa G; Ferguson J; Clemens R
    Scand J Infect Dis; 2011 Sep; 43(9):702-6. PubMed ID: 21534891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No serological evidence of influenza A H1N1pdm09 virus infection as a contributing factor in childhood narcolepsy after Pandemrix vaccination campaign in Finland.
    Melén K; Partinen M; Tynell J; Sillanpää M; Himanen SL; Saarenpää-Heikkilä O; Hublin C; Olsen P; Ilonen J; Nohynek H; Syrjänen R; Kilpi T; Vuorela A; Kirjavainen T; Vaarala O; Julkunen I
    PLoS One; 2013; 8(8):e68402. PubMed ID: 23950869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of AS03-adjuvanted influenza vaccines: A review of the evidence.
    Cohet C; van der Most R; Bauchau V; Bekkat-Berkani R; Doherty TM; Schuind A; Tavares Da Silva F; Rappuoli R; Garçon N; Innis BL
    Vaccine; 2019 May; 37(23):3006-3021. PubMed ID: 31031030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence rates of narcolepsy diagnoses in Taiwan, Canada, and Europe: The use of statistical simulation to evaluate methods for the rapid assessment of potential safety issues on a population level in the SOMNIA study.
    Dodd CN; de Ridder M; Huang WT; Weibel D; Giner-Soriano M; Perez-Vilar S; Diez-Domingo J; Svenson LW; Mahmud SM; Carleton B; Naus M; Kwong JC; Murray BJ; Arnheim-Dahlstrom L; Pedersen L; Morros R; Puertas FJ; Black S; Sturkenboom M
    PLoS One; 2018; 13(10):e0204799. PubMed ID: 30332477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies against ganglioside GM3 are associated with narcolepsy-cataplexy developing after Pandemrix vaccination against 2009 pandemic H1N1 type influenza virus.
    Saariaho AH; Vuorela A; Freitag TL; Pizza F; Plazzi G; Partinen M; Vaarala O; Meri S
    J Autoimmun; 2015 Sep; 63():68-75. PubMed ID: 26227560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Where are we in our understanding of the association between narcolepsy and one of the 2009 adjuvanted influenza A (H1N1) vaccines?
    Johansen K; Brasseur D; MacDonald N; Nohynek H; Vandeputte J; Wood D; Neels P;
    Biologicals; 2016 Jul; 44(4):276-280. PubMed ID: 27329008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The narcolepsy-pandemic influenza story: can the truth ever be unraveled?
    Sturkenboom MC
    Vaccine; 2015 Jun; 33 Suppl 2():B6-B13. PubMed ID: 26022571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Narcolepsy Associated with Pandemrix Vaccine.
    Sarkanen T; Alakuijala A; Julkunen I; Partinen M
    Curr Neurol Neurosci Rep; 2018 Jun; 18(7):43. PubMed ID: 29855798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.